Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
-
Ajax Therapeutics Announces FDA Clearance of IND Application for AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of Myelofibrosis
-
GXO Receives 2023 Whirlpool Supply Chain Supplier Awards
-
Cibus to Participate in the BMO Global Farm to Market Conference
-
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024
-
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
-
Get in on the Bonus Action at Juicy Stakes Casino
-
Village Farms International Appoints Finance and Operations Veteran Carolyn Hauger to Board
-
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates
-
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
CECO Environmental Announces Upcoming Investor Conferences
-
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
-
Iterum Therapeutics Reports First Quarter 2024 Financial Results
-
Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial
-
Signify share repurchase periodic update
-
MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy
-
Rego Payment Architectures Selected for ICBA ThinkTECH Accelerator Program
-
Total voting rights
-
Drilling Continues to Expand Gold Resource at OKO
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JOHN WOOD GROUP PLC - Ordinary Shares
-
AECOM selected by TxDOT to deliver drainage tunnels for I-35 Capital Express Central project in Austin, Texas
-
Bombardier Inaugurates New Aviator Lounge in the Principality of Monaco
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Avery Dennison Announces Upcoming Investor Events
-
Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Irish Residential Properties REIT PLC
-
Corrected Base Rate in certain BULL and BEAR certificates
-
Kenvue Announces Launch of Secondary Offering
-
Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk Melanoma
-
Canada Nickel Achieves Initial Metallurgical Success at Mann Northwest Property
-
Square Enix Holdings Co., Ltd. Announces Financial Results for the Fiscal Year Ended March 31, 2024
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
MKS Instruments Announces Proposed Private Offering of $1.0 Billion of Convertible Senior Notes
-
Permian Resources Corporation Announces Secondary Public Offering of Class A Common Stock
-
Kayne Anderson BDC, Inc. Announces Proposed Initial Public Offering
-
Mitek Announces $50 Million Share Repurchase Program
-
Mitek Reports Fiscal 2024 Second Quarter Financial Results and Reiterates 2024 Fiscal Full Year Guidance
-
Fortrea Reports First Quarter 2024 Results
-
"P-Stubbz801's 'Winning Friends': A Modern Anthem Inspired by the Timeless Art of Social Influence!"
-
Quarterhill Announces Q1 2024 Financial Results
-
Owens & Minor to Present at the BofA Securities 2024 Health Care Conference on May 15, 2024
-
Lifezone Metals Provides an Update on Operations and Unaudited Q1 2024 Financial Summary
-
Mirion Reminds Investors of Redemption of Public Warrants
-
Fisker Adds Three New U.S. Dealer Partners, in California and New Jersey; Waives $2,438 D&H Fee in U.S. on MY2023 Extremes and Ultras
-
Mitek Announces CEO Transition
-
IMPACT Community Capital Names Luke Rottmann as Managing Director of Investor Relations and Capital Markets
-
Ducommun Incorporated Earns Northrop Grumman Missions Systems’ Platinum Supplier Designation
-
Henry Schein Extends Partnership with Special Olympics Through 2025, Promoting Wellness and Health Education for Athletes with Intellectual Disabilities Around the World
-
K92 Mining Announces Strong 2024 Q1 Financial Results – Financial Position Strong as Stage 3 Expansion Advances


